Rock Edwin

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 30% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rock Edwin's trades of Crescent Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-24 2024-06-21
B Purchase
80,925 -36.0%
448.54
US$3,402,835 		80,925 -36.0% 448.54 US$3,402,835
2024-06-24 2024-06-20
B Purchase
81,920 +35.7%
42.59
US$1,303,409 		81,920 +35.7% 42.59 US$1,303,409
2023-09-25 2023-09-22
B Purchase
15,375 +44.7%
324.15
US$1,349,145 		15,375 +44.7% 324.15 US$1,349,145
2023-09-25 2023-09-21
B Purchase
35,000 +11.3%
1.38
US$48,300 		35,000 +11.3% 1.38 US$48,300
2022-12-27 2022-12-22
B Purchase
110,000 +55.0%
2.25
US$247,500 		110,000 +55.0% 2.25 US$247,500
2022-11-16 2022-11-15
B Purchase
100,000 +100.0%
1.66
US$166,000 		100,000 +100.0% 1.66 US$166,000
2022-11-16 2022-11-14
B Purchase
100,000 +inf%
1.43
US$143,000 		100,000 +inf% 1.43 US$143,000